• Home
  • Stock
  • Remus Pharmaceuticals Fundamental Analysis
  • Remus Pharmaceuticals Fundamental Analysis

Remus Pharmaceuticals fundamental analysis

REMUS

MiscellaneousSmall

686.05

5.95 (-0.86%)
Last updated on 4 Dec, 2025 | 13:04 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Remus Pharmaceuticals Fundamentals

P/E Ratio

28.05

P/B Ratio

3.12

Div. Yield

0.11

Sector P/E

39.29

Sector P/B

2.77

Sec. Div. Yield

91.58

  • Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 28.05, compared to the sector average of 39.29. Its P/B Ratio stands at 3.12, while the sector’s is 2.77. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 91.58%.

Remus Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.